Benefits
Skin elasticity and moisture
In a small 6-week randomized placebo-controlled trial in 36 men, 6 mg/day of oral astaxanthin improved crow's feet wrinkles and elasticity and reduced transepidermal water loss; skin moisture showed only a non-significant trend. A separate open-label arm in 30 women combined oral supplementation with topical astaxanthin, so its moisture and texture gains cannot be credited to oral intake alone. Both arms were run by the manufacturer.
Antioxidant defense
Astaxanthin quenches singlet oxygen and free radicals far more effectively than many common antioxidants, protecting cell membranes throughout the body.
Eye and visual comfort
In randomized placebo-controlled trials, including an AstaReal trial in children with heavy screen use, oral astaxanthin reduced digital eye-strain symptom scores; objective vision measures such as visual acuity and accommodation were mostly unchanged.
Exercise recovery
A meta-analysis of 24 randomized trials found oral astaxanthin lowered the muscle-damage markers creatine kinase and lactate dehydrogenase after exercise, but did not change the oxidative-stress marker malondialdehyde or interleukin-6, and did not improve VO2max, time-trial performance or power output.
Mechanism of action
Membrane-spanning antioxidant
The astaxanthin molecule sits across the full width of the cell membrane, letting it neutralize free radicals at both surfaces, a structural advantage over many antioxidants.
Anti-inflammatory signaling
Astaxanthin downregulates inflammatory mediators and supports antioxidant enzyme systems, contributing to its skin, eye, and recovery effects.
Clinical trials
Controlled human study of oral and topical astaxanthin on skin elasticity, moisture, and wrinkle appearance. (Tominaga et al. 2012, Acta Biochimica Polonica)
36 men (randomized, placebo-controlled, oral only) and 30 women (open-label, oral plus topical).
A randomized placebo-controlled arm in 36 men taking 6 mg/day oral astaxanthin for 6 weeks improved crow's feet wrinkles and elasticity and reduced transepidermal water loss; skin moisture showed only a non-significant trend. A separate open-label arm in 30 women combined oral and topical astaxanthin. The work was conducted by the manufacturer, Fuji Chemical Industries.